A significant delay in EG7 tumor growth was found in mice transferred with MDSC-treated CD62L+ T cells, compared to those receiving MDSC-exposed CD62L− counterparts or iMC-conditioned T cells (Figure 5A). The gene discussed is SELL; the disease is neoplasm.